| Protein kinase D as a potential new target for cancer therapy CR LaValle, KM George, ER Sharlow, JS Lazo, P Wipf, QJ Wang Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 183-192, 2010 | 126 | 2010 |
| Design, synthesis, and biological evaluation of PKD inhibitors KM George, MC Frantz, K Bravo-Altamirano, CR LaValle, M Tandon, ... Pharmaceutics 3 (2), 186-228, 2011 | 61 | 2011 |
| Synthesis and biological evaluation of 3-aminoisoquinolin-1 (2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B KMG Rosenker, WD Paquette, PA Johnston, ER Sharlow, A Vogt, ... Bioorganic & medicinal chemistry 23 (12), 2810-2818, 2015 | 45 | 2015 |
| Synthesis and Structure− Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D K Bravo-Altamirano, KM George, MC Frantz, CR LaValle, M Tandon, ... ACS medicinal chemistry letters 2 (2), 154-159, 2010 | 41 | 2010 |
| Synthesis of a library of tricyclic azepinoisoindolinones B Miller, S Mao, KMG Rosenker, JG Pierce, P Wipf Beilstein journal of organic chemistry 8 (1), 1091-1097, 2012 | 23 | 2012 |
| Regioselective palladium-catalyzed cross-coupling reactions of 2, 4, 7-trichloroquinazoline P Wipf, KM George Synlett: accounts and rapid communications in synthetic organic chemistry …, 2010 | 16 | 2010 |
| PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor AV Dix, JL Conroy, KM George Rosenker, DR Sibley, DH Appella ACS medicinal chemistry letters 6 (4), 425-429, 2015 | 11 | 2015 |
| Synthesis and structure-activity relationship of inhibitors of protein kinase D KMG Rosenker, K Bravo-Altamirano, MC Frantz, CR LaValle, M Tandon, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 244, 2012 | | 2012 |
